Molecure S.A. (WSE:MOC)
7.93
+0.74 (10.29%)
Jul 25, 2025, 5:00 PM CET
Molecure Revenue
Molecure had revenue of 597.71K PLN in the quarter ending March 31, 2025, with 2,001.81% growth. This brings the company's revenue in the last twelve months to 3.49M, up 80.48% year-over-year. In the year 2024, Molecure had annual revenue of 2.92M, down -20.08%.
Revenue (ttm)
3.49M
Revenue Growth
+80.48%
P/S Ratio
45.93
Revenue / Employee
37.11K
Employees
102
Market Cap
160.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.92M | -733.54K | -20.08% |
Dec 31, 2023 | 3.65M | -3.86M | -51.39% |
Dec 31, 2022 | 7.51M | 6.35M | 543.32% |
Dec 31, 2021 | 1.17M | -123.74M | -99.07% |
Dec 31, 2020 | 124.91M | 122.90M | 6,100.72% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.82B |
Voxel | 556.98M |
Synektik Spólka Akcyjna | 592.94M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |
EMC Instytut Medyczny | 836.81M |